PipelineReview.com - Target Pipelines

Show Cart

Target Pipelines

Results 11 - 20 of 54

Aug 2023 CD40 Agonists & CD40/L Antagonists Pipeline Review

Aug 2023 Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review

Aug 2023 Folate Receptor alpha (FRα) Targeted Therapy Pipeline Review

Aug 2023 IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline Review

Jul 2023 Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review

Jul 2023 Competitor Analysis: Complement C5 Inhibitors & C5 Receptor Antagonists

Jul 2023 Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review

Jul 2023 Adalimumab (Humira) Biosimilars Pipeline Review

Jun 2023 Ranibizumab (Lucentis) Biosimilars Pipeline Review

Jun 2023 Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review

Shopping cart

Cart empty

Latest report

B7-H3-Targeted Immunotherapy Candidates Pipeline Review

Featured Products

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

DLL3-Targeted Immunotherapy Candidates Pipeline Review

Shopping cart

Cart empty

Latest report

B7-H3-Targeted Immunotherapy Candidates Pipeline Review

Featured Products

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

DLL3-Targeted Immunotherapy Candidates Pipeline Review

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing